DI
SGMT icon

DUMAC Inc’s Sagimet Biosciences SGMT Stock Holding History

DUMAC Inc’s Portfolio SGMT Stock Details SGMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$372K Hold
71,192
– – 0.05% 9
2025
Q4 		$421K Buy
+71,192
New +$512K 0.06% 9
2025
Q2 		$572K Sell
75,000
-72,351
-49% -$305K 3.59% 6
2025
Q1 		$480K Sell
147,351
-16,163
-10% -$67.8K 1.92% 9
2024
Q4 		$736K Sell
163,514
-25,880
-14% -$131K 1.14% 7
2024
Q3 		$525K Hold
189,394
– – 1.7% 8
2024
Q2 		$648K Hold
189,394
– – 2.07% 8
2024
Q1 		$1.03M Sell
189,394
-14,729
-7% -$106K 3.72% 7
2023
Q4 		$1.11M Hold
204,123
– – 3.41% 7
2023
Q3 		$1.8M Buy
+204,123
New +$2.72M 4.82% 6

Other funds holding SGMT

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

DUMAC Inc's SGMT Position: Q1 2026 in Review

DUMAC Inc held its Sagimet Biosciences (SGMT) position steady in Q1 2026 at 71,192 shares worth $372K. The position accounts for 0.05% of the portfolio, ranked #9.

DUMAC Inc first reported a position in SGMT in Q3 2023 and has held it in 10 quarters since. The position peaked at $1.8M in Q3 2023. 88 funds tracked by Wall St. Rank hold SGMT as of Q1 2026.

  • DUMAC Inc held 71,192 shares of Sagimet Biosciences worth $372K as of Q1 2026.
  • DUMAC Inc left its Sagimet Biosciences share count unchanged in Q1 2026.
  • Sagimet Biosciences made up 0.05% of DUMAC Inc's portfolio in Q1 2026, its #9 holding.
  • DUMAC Inc first reported a position in Sagimet Biosciences in Q3 2023 and has held it in 10 quarters since.
  • DUMAC Inc's Sagimet Biosciences position peaked at $1.8M in Q3 2023.
  • 88 funds tracked by Wall St. Rank held Sagimet Biosciences as of Q1 2026.

Based on DUMAC Inc's 13F filing for Q1 2026, filed 1 May 2026.